Key result
Biohybrid RV patch improves LVEF by ~14% and TAPSE vs sham in rat heart failure.
Why the study?
In right heart failure secondary to pulmonary artery banding, an elastic, biodegradable epicardial patch with integrated extracellular matrix digest was evaluated for its potential to inhibit disease progression.
Does epicardial placement of an elastic, biohybrid patch improve cardiac function and reduce remodeling in a rat model of right heart failure with pulmonary artery banding?
Population
Adult male syngeneic Lewis rats aged 6-7 weeks old after pulmonary artery banding
Comparison
Epicardial biohybrid cardiac patch (n = 7) vs sham (n = 10)
Design
Animal experimental study
Follow-up
9 weeks after PAB
Authors
Loading...
Hypothesis-generating in rat right heart failure; leaves open translation of biohybrid patch benefits to larger models or clinical use.
Does epicardial placement of an elastic, biohybrid patch improve cardiac function and reduce remodeling in a rat model of right heart failure with pulmonary artery banding?
Absolute Event Rate: 49.9% vs 35.9%
p-value: p=<0.001
In a rat model of right heart failure with fixed afterload, epicardial application of an elastic biohybrid patch improved biventricular function, moderated pressure stress, and reduced right ventricular fibrosis.
Hayashi et al. (2025) studied Right heart failure secondary to pulmonary artery banding (n=21). Elastic, biohybrid patch (PECUU-cardiac ECM hydrogel) vs. Sham procedure was evaluated on Left ventricular ejection fraction (p=<0.001). Placement of a degradable, biohybrid patch onto the right ventricle in a rat model of right heart failure improved left ventricular ejection fraction and tricuspid annular plane systolic excursion compared to sham surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: